BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1508850)

  • 1. Mutation analysis for prenatal diagnosis and heterozygote detection of Gaucher disease type III (Norrbottnian type).
    Dahl N; Wadelius C; Annerén G; Gustavson KH
    Prenat Diagn; 1992 Jul; 12(7):603-8. PubMed ID: 1508850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliable co-segregation analysis for prenatal diagnosis and heterozygote detection in Gaucher disease.
    Cormand B; Montfort M; Chabás A; Grinberg D; Vilageliu LL
    Prenat Diagn; 1998 Mar; 18(3):207-12. PubMed ID: 9556036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gaucher disease type III (Norrbottnian type) is caused by a single mutation in exon 10 of the glucocerebrosidase gene.
    Dahl N; Lagerström M; Erikson A; Pettersson U
    Am J Hum Genet; 1990 Aug; 47(2):275-8. PubMed ID: 2378352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal diagnosis of Gaucher disease using next-generation sequencing.
    Yoshida S; Kido J; Matsumoto S; Momosaki K; Mitsubuchi H; Shimazu T; Sugawara K; Endo F; Nakamura K
    Pediatr Int; 2016 Sep; 58(9):946-9. PubMed ID: 27682613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proof-of-principle rapid noninvasive prenatal diagnosis of autosomal recessive founder mutations.
    Zeevi DA; Altarescu G; Weinberg-Shukron A; Zahdeh F; Dinur T; Chicco G; Herskovitz Y; Renbaum P; Elstein D; Levy-Lahad E; Rolfs A; Zimran A
    J Clin Invest; 2015 Oct; 125(10):3757-65. PubMed ID: 26426075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 Gaucher disease with hydrops fetalis in an Ashkenazi Jewish family resulting from a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus.
    Reissner K; Tayebi N; Stubblefield BK; Koprivica V; Blitzer M; Holleran W; Cowan T; Almashanu S; Maddalena A; Karson EM; Sidransky E
    Mol Genet Metab; 1998 Apr; 63(4):281-8. PubMed ID: 9635296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal lethality of a homozygous null mutation in the human glucocerebrosidase gene.
    Tayebi N; Cushner SR; Kleijer W; Lau EK; Damschroder-Williams PJ; Stubblefield BK; Den Hollander J; Sidransky E
    Am J Med Genet; 1997 Nov; 73(1):41-7. PubMed ID: 9375921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tight linkage between type III Gaucher's disease (Norrbottnian type) and a MspI polymorphism within the gene for human glucocerebrosidase.
    Dahl N; Erikson A; Hammarström-Heeroma K; Pettersson U
    Genomics; 1988 Nov; 3(4):296-8. PubMed ID: 2468600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state.
    Beutler E; Gelbart T; Kuhl W; Sorge J; West C
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10544-7. PubMed ID: 1961718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restriction fragment length polymorphism analysis in healthy Japanese individuals and Japanese families with Gaucher disease.
    Masuno M; Orii T; Sukegawa K; Taga T
    Acta Paediatr Jpn; 1989 Apr; 31(2):158-62. PubMed ID: 2576337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation analysis of type II Gaucher disease in five Taiwanese children: identification of two novel mutations.
    Tsai FJ; Lee CC; Wu MC; Lin SP; Lin CY; Tsai CH; Kodama H; Wu JY
    Acta Paediatr Taiwan; 2001; 42(4):231-5. PubMed ID: 11550412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prenatal diagnosis of Gaucher disease].
    Germain DP; Benistan K
    Rev Med Interne; 2007 Oct; 28 Suppl 2():S193-7. PubMed ID: 18240370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two novel (1098insA and Y313H) and one rare (R359Q) mutations detected in exon 8 of the beta-glucocerebrosidase gene in Gaucher's disease patients.
    Cormand B; Vilageliu L; Balcells S; Gonzàlez-Duarte R; Chabás A; Grinberg D
    Hum Mutat; 1996; 7(3):272-4. PubMed ID: 8829663
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mutation analysis of mucopolysaccharidosis type II and prenatal diagnosis].
    Liu N; Shi H; Kong X; Wu Q; Jiang M
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):410-3. PubMed ID: 25169630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of the novel mutation IVS 8 (-11delC) (-14T>A) in the intron 8 of the glucocerebrosidase gene of two Italian siblings with Gaucher disease type I.
    Romano M; Danek GM; Baralle FE; Mazzotti R; Filocamo M
    Blood Cells Mol Dis; 2000 Jun; 26(3):171-6. PubMed ID: 10950936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of an Ashkenazi Jewish family with Gaucher disease in three successive generations.
    Kolodny EH; Firon N; Eyal N; Horowitz M
    Am J Med Genet; 1990 Aug; 36(4):467-72. PubMed ID: 2117855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous presence of the crossover (fusion gene) mutation identified in a type II Gaucher disease fetus: is this analogous to the Gaucher knock-out mouse model?
    Strasberg PM; Skomorowski MA; Warren IB; Hilson WL; Callahan JW; Clarke JT
    Biochem Med Metab Biol; 1994 Oct; 53(1):16-21. PubMed ID: 7857677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel point mutation (D380A) and a rare deletion (1255del55) in the glucocerebrosidase gene causing Gaucher's disease.
    Walley AJ; Harris A
    Hum Mol Genet; 1993 Oct; 2(10):1737-8. PubMed ID: 8268935
    [No Abstract]   [Full Text] [Related]  

  • 19. Antenatal diagnosis.
    Old JM; Ludlam CA
    Baillieres Clin Haematol; 1991 Apr; 4(2):391-428. PubMed ID: 1680511
    [No Abstract]   [Full Text] [Related]  

  • 20. Carrier screening for Gaucher disease: lessons for low-penetrance, treatable diseases.
    Zuckerman S; Lahad A; Shmueli A; Zimran A; Peleg L; Orr-Urtreger A; Levy-Lahad E; Sagi M
    JAMA; 2007 Sep; 298(11):1281-90. PubMed ID: 17878420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.